Here’s Why Bio-Rad Laboratories (BIO) Traded Lower in Q1
Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor letter.
Posts Tagged ‘NYSE:BIO’
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2025 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2025 Earnings Call Transcript May 1, 2025Bio-Rad Laboratories, Inc. beats earnings expectations.
Billionaire Mason Hawkins’ 10 Small-Cap Stocks with Huge Upside Potential
Mason Hawkins is a prominent American investor, known for being the founder and chairman of Southeastern Asset Management.
Does Bio-Rad Laboratories (BIO) Offer a Solid Financial Profile?
Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” first-quarter 2025 investor letter.
Should You be Optimistic on Bio-Rad Laboratories’s (BIO) Outlook?
Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
7 Best Medical Technology Stocks To Buy According To Analysts
The MedTech sector is crucial in healthcare, which concentrates on the creation of medical devices aimed at enhancing disease prevention, diagnosis, and treatment.
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2024 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2024 Earnings Call Transcript February 13, 2025Bio-Rad Laboratories, Inc. beats earnings expectations.
Retirement Stock Portfolio: 10 Healthcare Stocks to Buy
Healthcare stocks are widely considered a cornerstone of a retirement portfolio due to their resilience, long-term growth potential, and ability to provide steady income through...
Bio-Rad Laboratories, Inc. (BIO): A Bull Case Theory
We came across a bullish thesis on Bio-Rad Laboratories, Inc. (BIO) on Substack by Stock Analysis Compilation. In this article, we will summarize the bulls’ thesis on BIO.
What Makes Bio-Rad Laboratories (BIO) an Attractive Opportunity?
Ariel Investments, an investment management company, released its “Ariel Focus Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q3 2024 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q3 2024 Earnings Call Transcript October 30, 2024Bio-Rad Laboratories, Inc. beats earnings expectations.
Bio-Rad Laboratories (BIO) is a Classic Ariel Stock: Ariel Fund
Ariel Investments, an investment management company, released its “Ariel Fund” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Organ Transplant and Diagnosis Stocks To Buy Now
In the dynamic landscape of healthcare, the importance of organ transplantation cannot be overstated.
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q2 2024 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q2 2024 Earnings Call Transcript August 1, 2024Bio-Rad Laboratories, Inc. beats earnings expectations.
Bio-Rad Laboratories’ (BIO) Growth Tailwinds Are Delayed, Not Derailed
Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” second quarter 2024 investor letter.
Is Bio-Rad Laboratories (BIO) a Lucrative Investment?
Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” first-quarter 2024 investor letter. A copy of the letter can be downloaded here...
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript
Operator: Good afternoon everyone, and welcome to today's Bio-Rad First Quarter 2024 Earnings Results Conference Call. At this time, all lines are in a listen-only mode.
Billionaires Mario Gabelli and Mason Hawkins Love These 5 Stocks
This article presents an overview of the Billionaires Mario Gabelli and Mason Hawkins Love These 5 Stocks.
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2023 Earnings Call Transcript
Bio-Rad Laboratories, Inc. beats earnings expectations. Reported EPS is $3.1, expectations were $2.93.
Billionaire Mason Hawkins’ 5 Stock Picks with Huge Upside Potential
This article presents an overview of the Billionaire Mason Hawkins' 5 Stock Picks with Huge Upside Potential. For a detailed overview of such stocks, read our article, Billionaire...
5 Beaten Down Stocks Billionaires Are Crazy About
In this article, we will take a look at the 5 beaten down stocks billionaires are crazy about.
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to the Bio-Rad Third Quarter 2023 Financial Results Conference Call and Webcast.
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen and welcome to the Bio-Rad Second Quarter 2023 Earnings Results Conference Call.
10 Beaten Down Stocks Billionaires Are Loading Up On
In this piece, we will take a look at ten beaten down stocks billionaires are loading up on.
5 Best Future Stocks for the Long-Term
Bio-Rad Laboratories, Inc. (NYSE:BIO) is a medical devices company headquartered in Hercules, California.
15 Healthcare Stocks Billionaires Are Loading Up On
In this article, we discuss 15 best healthcare stocks billionaires are loading up on.
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2023 Earnings Call Transcript
Operator: Good afternoon. Thank you for attending the Bio-Rad First Quarter 2023 Earnings Conference Call. My name is Matt, and I'll be your moderator for today's call.
13 Best Medical Stocks To Invest In
The global healthcare sector has been permanently transformed by the COVID-19 pandemic, which has resulted in a faster adoption of novel technologies and care delivery methods...
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Thank you for attending today's Bio-Rad Fourth Quarter and Full Year 2022 Earnings Results Conference Call.
11 Best Medical Technology Stocks To Buy
The global medical devices market is expected to grow from $495.46 billion in 2022 to $718.92 billion by 2029 at a CAGR of 5.5% during the forecast period.
Retirement Stock Portfolio: 11 Safe Healthcare Stocks to Consider
In this article, we discuss the 11 safe healthcare stocks for a retirement stock portfolio.
15 Biggest Medical Device Companies in the World
In this article, we will take a look at the 15 biggest medical device companies in the world.
Top 10 Healthcare Stocks to Buy
Focus in the healthcare sector has steadily been shifting away from the coronavirus pandemic to diversification, vertical integration, and new business building in the past few...
Levin Easterly Partners’ Latest Portfolio: Top 10 Stock Picks
This article discusses the top 10 stock picks of Levin Easterly Partners at the end of the second quarter of 2022.
12 Best Healthcare Stocks To Buy Now
In this piece, we will take a look at the twelve best healthcare stocks to buy now.
10 Stocks Billionaire Ken Fisher May Never Sell
Chevron Corporation (NYSE:CVX), Merck & Co., Inc.
Billionaire Cliff Asness Was Relentlessly Buying Meta Platforms (META) and These 4 Stocks in Q1
Below we take a look at why Billionaire Cliff Asness Was Relentlessly Buying Meta Platforms (META) and These 4 Stocks in Q1.
Investors are Watching These 10 Biotech Stocks
In this article, we discuss the 10 biotech stocks that investors are watching.
Billionaire Mario Gabelli is Dumping These 5 Stocks in 2022
In this article, we discuss the 5 stocks billionaire Mario Gabelli is dumping in 2022.
Mario Gabelli is Selling These 5 Stocks in 2022
In this article, we will look at the top 5 stocks billionaire Mario Gabelli sold in 2022.
10 Biotech Stocks to Buy Today According to Ken Fisher
In this piece, we will take a look at the ten biotechnology stocks to buy according to Ken Fisher's Fisher Asset Management.
10 Best Healthcare Stocks To Buy In 2022
In this article, we discuss 10 best healthcare stocks to buy in 2022.
Were Hedge Funds Right About Bio-Rad Laboratories, Inc. (BIO)?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
Top 5 Stock Picks of Paul Marshall and Ian Wace’s Marshall Wace LLP
In this article, we discuss the top 5 stock picks of Paul Marshall and Ian Wace’s Marshall Wace LLP.
Hedge Funds Are Selling Bio-Rad Laboratories, Inc. (BIO)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
10 Biotech Stocks to Buy According to Billionaire Ken Fisher
In this article, we discuss the 10 biotech stocks to buy according to billionaire Ken Fisher.
10 Healthcare Stocks to Buy According to John Rogers’ Ariel Investments
In this article, we will take a look at the 10 healthcare stocks to buy according to John Rogers’ Ariel Investments.
11 Best Genomic Stocks to Buy Now
In this article, we will take a look at the 11 best genomic stocks to buy now.
Hedge Funds Aren’t Crazy About Bio-Rad Laboratories, Inc. (BIO) Anymore
In this article we will take a look at whether hedge funds think Bio-Rad Laboratories, Inc. (NYSE:BIO) is a good investment right now.
Paul Marshall and Ian Wace’s Top 5 Stock Picks
In this article, we discuss the Paul Marshall and Ian Wace's top 5 stock picks.
